FDA request delays timeline for Sanofi’s iGlarLixi drug-device combo for diabetes

August 24, 2016 By MassDevice Leave a Comment

By Sarah Faulkner

The FDA’s request for more data on the iGlarLixi drug-device combination for treating Type II diabetes pushed the timeline for a decision back 3 months, Sanofi (NYSE:SNY) and Zealand Pharma (CPH:ZEAL) said last week.

Sanofi said August 19 that it submitted a new data package for iGlarLixi, an injection pen designed to deliver a once-daily dose of Sanofi’s Lantus insulin glargine and the lixisenatide drug it licensed from Zealand Pharma.

Sanofi licensed the development and commercialization rights to lixisenatide in 2003, and expanded the deal to include drug-device combinations. The deal involves up to $135 million in milestone payments for Zealand.

Sanofi submitted a new drug application for iGlarLixi in December 2015, spending $245 million to gain priority review, which the FDA granted in February. An advisory panel recommended approval in May, setting the stage for a decision by the end of the summer. The FDA’s request for additional information pushes the decision date back to November 2016.

Despite the delay, Zealand said it’s still confident that the new data will help lead to FDA approval; the delay won’t affect its financial guidance, the company said.

“IGlarLixi is a combination of 2 already FDA-approved diabetes medicines and has in clinical trials demonstrated significant benefits for adults with Type II diabetes,” president & CEO Britt Meelby Jensen said in prepared remarks. “The combination received a convincing positive recommendation for approval by an FDA advisory committee in May, and Sanofi believes that the additional information submitted will result in an offering that will serve the patient needs.”

The delay is a blow to Sanofi’s attempt to get the device to market before a similar device by rival Novo Nordisk (NYSE:NVO) is approved. The FDA is set to deliver a decision on Novo Nordisk’s device, iDeglira/Xultophy, next month.

ZEAL shares are off -9.5% to about $16.65 (DKK 110) since the news broke last week; SNY shares are down -1.6% to $39.13 over the same period.

($1 = DKK 6.60710)

Hospital survey reveals front-line needs, desperate measures
Hospitals across the U.S. have begun resorting to unorthodox means of replacing or sanitizing personal protective equipment (PPE) and atypical sourcing of PPE and other supplies needed to fight the coronavirus pandemic, according to a government survey. The Department of Human Services’ Office of the Inspector General (OIG) conducted the random survey of 323 hospitals… […]
CDRH gives medtech manufacturers employee coronavirus safety tips
As certain medtech companies continue ramping up production of devices and components to fight the coronavirus, the FDA’s Center for Devices and Radiological Health (CDRH) on Sunday announced several tips to help protect medtech manufacturing employees from contracting COVID-19. In addition to frequent and thorough hand-washing, maintaining social distancing and avoiding face-touching, the agency urged… […]
Lin Engineering hastens manufacture of DC motors for fight against COVID-19
Lin Engineering — a designer and manufacturer of precision electric motors and motion systems — is prioritizing the production and supply of motors to support companies making medical devices critical in the treatment of COVID-19 patients. Morgan Hill, Calif.-based Lin Engineering said last week its highest priority is supplying motors to the makers of medical… […]
Nortech, Minnetronix may start building ventilators
Two Minnesota medtech contract manufacturers are taking a hard look at producing ventilators, including one from the plans that Medtronic made public last week to address the coronavirus outbreak. Maple Grove-based Nortech Systems (NSDQ:NSYS) told Medical Design & Outsourcing it is seriously considering starting to produce the machines based on the design specifications of Medtronic’s… […]
Materialise touts 3D-printed oxygen mask that could free up ventilators
Materialise announced today that it developed a 3D-printed device to convert standard hospital equipment into a mask to help patients breathe by creating positive pressure in the lungs. The Leuven, Belgium-based company’s Materialise NIP Connector is designed to give clinicians the ability to reduce the time that patients need access to ventilators and relieve the… […]
Plastikos implements bio-contamination testing and compliance under ISO 14698
Plastikos (Erie, Pa.) recently announced that it has implemented a formal bio-contamination testing and compliance system that’s in full compliance with ISO 14698-1 and ISO 14698-2 — a move the company described as paramount amid the COVID-19 pandemic. Plastikos and Plastikos Medical presently mold medical devices and parts within multiple ISO-7 certified cleanrooms. The new… […]
How 3D printing is enabling ventilator splitting
Amid the shortage of ventilators due to the COVID-19 pandemic, researchers are finding success using 3D printing to enable “ventilator splitting.” The search continues to go on for more machines, but there have already been government actions taken to increase amounts, while researchers have taken it into their own hands to create homemade-style ventilators. However,… […]
How R&D departments are coping with coronavirus
Hardly anyone’s R&D workplace has been spared all the repercussions of the COVID-19 crisis. People are working remotely, staggering their hours in laboratories to avoid too many coworkers, and relying heavily on conference calls and video meetings. Our WTWH Media sister site R&D World spoke to a few industry people to see how they’re coping… […]
Europe waives tariffs, import taxes on COVID-19 medtech
The European Commission has decided to waive tariffs and value-added taxes (VAT) on certain medical devices and personal protective equipment (PPE) coming from outside the EU during the coronavirus pandemic. The measure includes testing kits, ventilators and other medical equipment and will remain in force for six months, the commission said today. “In this emergency,… […]
FDA eases mask regulations, seeks to boost decontamination of used masks
The FDA yesterday further relaxed regulations on medical and surgical masks and face shields to ease shortages during the coronavirus pandemic, and invited companies that decontaminate masks to submit proposals for emergency authorizations. In a new guidance, the agency also gave its blessing to healthcare providers to use improvised masks during the public health emergency when… […]
BARDA opens research portal to fight COVID-19
By James Keller, Emergo Group The Biomedical Advanced Research and Development Authority (BARDA), which is part of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response, is seeking information from stakeholders on available medical countermeasures in development. It is particularly interested in products and technologies that have progressed into… […]